BRPI0509740A - compostos para tratamento das arritmias cardìacas e métodos de uso - Google Patents

compostos para tratamento das arritmias cardìacas e métodos de uso

Info

Publication number
BRPI0509740A
BRPI0509740A BRPI0509740-1A BRPI0509740A BRPI0509740A BR PI0509740 A BRPI0509740 A BR PI0509740A BR PI0509740 A BRPI0509740 A BR PI0509740A BR PI0509740 A BRPI0509740 A BR PI0509740A
Authority
BR
Brazil
Prior art keywords
methods
treatment
compounds
cardiac arrhythmias
cardiac
Prior art date
Application number
BRPI0509740-1A
Other languages
English (en)
Portuguese (pt)
Inventor
Pascal Druzgala
Original Assignee
Aryx Therapeutics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aryx Therapeutics filed Critical Aryx Therapeutics
Publication of BRPI0509740A publication Critical patent/BRPI0509740A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BRPI0509740-1A 2004-04-09 2005-04-08 compostos para tratamento das arritmias cardìacas e métodos de uso BRPI0509740A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US56091704P 2004-04-09 2004-04-09
PCT/US2005/012138 WO2005099684A1 (en) 2004-04-09 2005-04-08 Benzofuranyl derivatives useful for the treatment of cardiac arrhythmia

Publications (1)

Publication Number Publication Date
BRPI0509740A true BRPI0509740A (pt) 2007-09-25

Family

ID=34965215

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0509740-1A BRPI0509740A (pt) 2004-04-09 2005-04-08 compostos para tratamento das arritmias cardìacas e métodos de uso

Country Status (14)

Country Link
US (3) US7105568B2 (enExample)
EP (1) EP1732537A1 (enExample)
JP (1) JP2007532576A (enExample)
KR (1) KR20070001259A (enExample)
CN (1) CN1950080A (enExample)
AU (1) AU2005232701A1 (enExample)
BR (1) BRPI0509740A (enExample)
CA (1) CA2560336A1 (enExample)
IL (1) IL178127A0 (enExample)
MX (1) MXPA06011647A (enExample)
NO (1) NO20065156L (enExample)
RU (1) RU2373199C2 (enExample)
WO (1) WO2005099684A1 (enExample)
ZA (1) ZA200607666B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1732537A1 (en) * 2004-04-09 2006-12-20 Aryx Therapeutics Benzofuranyl derivatives useful for the treatment of cardiac arrhythmia
RU2446143C2 (ru) * 2010-05-19 2012-03-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ярославский государственный технический университет" (ЯГТУ) Способ получения эфиров замещенных 5,6-дицианобензофуран-2-карбоновых кислот
CN108396016B (zh) * 2018-02-05 2021-05-25 中国科学院南海海洋研究所 一种酯酶phe21及其编码基因和在手性乙酸仲丁酯制备中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2550091B1 (fr) * 1983-08-02 1986-05-23 Sanofi Sa Composition pharmaceutique ou veterinaire destinee a combattre des troubles ischemiques cardiaques contenant un derive du benzofuranne
US5175187A (en) * 1989-03-06 1992-12-29 Soorianarain Baligadoo Synergistic compositions for the treatment of coronary insufficiency and methods of use thereof
US5364880A (en) * 1993-06-16 1994-11-15 Advanced Therapies, Inc. Compound for treatment of cardiac arrhythmia, synthesis, and methods of use
US6309823B1 (en) * 1993-10-26 2001-10-30 Affymetrix, Inc. Arrays of nucleic acid probes for analyzing biotransformation genes and methods of using the same
US6121278A (en) * 1997-09-03 2000-09-19 Guilford Pharmaceuticals, Inc. Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity
RU2138492C1 (ru) * 1997-12-23 1999-09-27 Пятигорская государственная фармацевтическая академия Способ синтеза производных 3-(5-метилфур-2-ил)-бензофурана, обладающих гипотензивной, антиангинальной и антиаритмической активностями
DE60035888T2 (de) * 1999-10-15 2007-12-06 Aryx Therapeutics, Fremont Enantiomere verbindungen zur behandlung von herzrythmusstörungen und verfahren zu ihrer anwendung
EP1451169A1 (en) * 2001-12-10 2004-09-01 ARYx Therapeutics Novel compounds for the treatment of cardiac arrhythmia, synthesis, and methods of use
US7015568B2 (en) * 2003-08-21 2006-03-21 Texas Instruments Incorporated System for ultraviolet atmospheric seed layer remediation
EP1732537A1 (en) * 2004-04-09 2006-12-20 Aryx Therapeutics Benzofuranyl derivatives useful for the treatment of cardiac arrhythmia

Also Published As

Publication number Publication date
IL178127A0 (en) 2006-12-31
NO20065156L (no) 2006-11-09
RU2373199C2 (ru) 2009-11-20
US7105568B2 (en) 2006-09-12
US20080114059A1 (en) 2008-05-15
CN1950080A (zh) 2007-04-18
MXPA06011647A (es) 2007-04-13
RU2006139649A (ru) 2008-05-20
ZA200607666B (en) 2008-03-26
CA2560336A1 (en) 2005-10-27
JP2007532576A (ja) 2007-11-15
EP1732537A1 (en) 2006-12-20
WO2005099684A1 (en) 2005-10-27
US7351842B2 (en) 2008-04-01
AU2005232701A1 (en) 2005-10-27
US20060276535A1 (en) 2006-12-07
KR20070001259A (ko) 2007-01-03
US20050228045A1 (en) 2005-10-13

Similar Documents

Publication Publication Date Title
GT200600092A (es) Alargar el tiempo hasta la progresion de la enfermedad o la supervivencia de los pacientes de cancer
CL2004000639A1 (es) Compuestos derivados de quinolina y quinoxalina, composicion farmaceutica, combinacion farmaceutica; kit farmaceutico; y su uso para tratar aterosclerosis, enfermedad de arteria coronaria, enfermedad cardiaca coronaria, enfermedad vascular coronaria,
NO20082298L (no) Kaliumkanalinhibitorer
UA94221C2 (en) Lipocalin protein
CL2009000349A1 (es) Compuestos derivados de 4,5-dihidro-oxazol-2-ilamina; procedimiento de preparacion; composicion farmaceutica; y su uso para el tratamiento de la enfermedad de alzheimer.
DK1565136T3 (da) Sammensætninger for transdermal oxybutynin-terapi
NO20083002L (no) Fremgangsmate for anvendelse av CD40-bindende forbindelser
CL2010001123A1 (es) Uso de piridin-3-ilmetil docosahexanoato para preparar un medicamento util para la prevencion y/o el tratamiento de enfermedades cardiovasculares (divisional solicitud 1848-07).
TW200509892A (en) Novel aminobenzophenone compounds
CL2007002384A1 (es) Uso de compuestos derivados de 2,5-dihidroxibenceno para el tratamiento de la psoriasis.
ATE527241T1 (de) Pyridiazinonderivate zur behandlung von tumoren
NO20080412L (no) Ny fysiologisk forbindelse Nesfatin, forbindelse relevant dertil og anvendelse av forbindelsene
PT2056805E (pt) Utilização de derivados de 2,5-di-hidroxibenzeno para o tratamento de reacção tecidular
DK1863899T3 (da) Hudbehandlingspræparater
ATE473735T1 (de) Beta-2 adrenoceptor agonisten zur behandlung von bindegewebserkrankungen der haut
ATE549024T1 (de) Chinazolin-kaliumkanalhemmer
ZA200710111B (en) New oxabispidine compounds for the treatment of cardiac arrhythmias
WO2006089871A3 (en) Diphenylurea derivatives useful as erg channel openers for the treatment of cardiac arrhythmias
BRPI0508350A (pt) métodos para interferir com fibrose
BRPI0509740A (pt) compostos para tratamento das arritmias cardìacas e métodos de uso
UY29723A1 (es) Uso de arilanilidas para tratamiento de semillas
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
GB0521716D0 (en) Modulation of 11beta-hydroxysteriod dehydrogenase 1 expression for the treatment of ocular diseases
UY29859A1 (es) Derivados de 1-amino-isiquinolina,su preparación y su aplicación terapéutica
FI20040180L (fi) Koostumus psoriasis-taudin hoitamiseksi

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.